Method | % (correct no./total no.) 95% CI | ||||
---|---|---|---|---|---|
Sensitivity | Specificity | PPV | NPV | ||
For culture-positive TB patients (n = 11) | AFB | 63.6 (7/11) 31.6–87.6 | 100 (47/47) 90.6–100 | 100 (7/7) 56.1–100 | 92.2 (47/51) 80.3–97.5 |
Pathology | 72.7 (8/11) 39.3–92.7 | 85.1 (40/47) 71.1–93.3 | 53.3 (8/15) 27.4–77.8 | 93.0 (40/43) 79.9–98.2 | |
Xpert | 90.9 (10/11) 57.1–99.5 | 89.4 (42/47) 76.1–96.0 | 66.7 (10/15) 38.7–87.0 | 97.7 (42/43) 86.2–99.9 | |
Ultra | 90.9 (10/11) 57.1–99.5 | 59.6 (28/47) 44.3–73.3 | 34.5 (10/29) 18.6–54.3 | 96.6 (28/29) 80.4–99.8 | |
For culture-positive and negative TB patients (n = 96) | AFB | 8.3 (8/96) 3.9–16.2 | 100 (47/47) 90.6–100 | 100 (8/8) 59.8–100 | 34.8 (47/135) 27.0–43.5 |
Culture | 11.5 (11/96) 6.1–20.0 | 100 (47/47) 90.6–100 | 100 (11/11) 67.9–100 | 35.6 (47/132) 27.6–44.5 | |
Pathology | 42.7 (41/96) 32.8–53.2 | 85.1 (40/47) 71.1–93.3 | 85.4 (41/48) 72.8–92.8 | 42.1 (40/95) 32.2–52.7 | |
Xpert | 64.6 (62/96)a 54.1–73.9 | 89.4 (42/47) 76.1–96.0 | 92.5 (62/67) 86.1–99.0 | 55.3 (42/76) 43.8–66.7 | |
Ultra | 78.1 (75/96)a 68.3–85.7 | 59.6 (28/47) 44.3–73.3 | 79.8 (75/94) 71.5–88.1 | 57.1 (28/49) 42.8–71.5 |